Excessive proinflammatory responses over anti-inflammatory pathways are an integral component of peripheral tissue degeneration in the course of metabolic syndrome onset; therefore, the influence of PTP1B inhibition on EMS-mediated anti-inflammatory mechanisms depletion has been further evaluated. This evidence concerns the gene PTPN1 and metabolic syndrome.